In many situations, the answer depends on distribution channels and intended use
Other additions to Category 1 include ruxolitinib phosphate, a JAK1and JAK2 inhibitor currently commercially available orally and topically for conditions such as myelofibrosis or atopic dermatitis respectively and dimercaprol,a chelating drug currently commercially-available as an injectable
Over time, our bodies produce fewer peptides, affecting everything from our skin and hair to our metabolism and energy levels
Because Dihexa activates HGF/c-Met signaling , and this pathway is also involved in some types of tumor progression, caution is advised in: Patients with active cancers History of certain malignancies No human data confirms a cancer risk, but Dihexa is best avoided in patients with cancer unless under strict clinical supervision
Reporting from the meeting noted that committee members opposing inclusion also questioned whether a compounding pathway would reduce online sales and whether the thin evidence justified routine availability
FASEB J 29:13951403
